Over 200 risk loci for IBD have been identified through genome-wide association studies [GWAS], with many in key regulatory pathways.1,11 The single nucleotide polymorphism [SNP] rs61839660 denotes a cytosine [C] to thymidine [T] base change on chromosome 10, located within a putative intronic enhancer region [intron 7] of IL2RA. This evidence concerns the gene IL2RA and inflammatory bowel disease.